European Stocks Tumble Amid New Tariff Shockwaves

European shares ended flat after initial gains were erased by U.S. President Trump's tariff threat on pharmaceutical imports. Healthcare stocks were hit hardest, with Novo Nordisk experiencing a drop in share value. Swiss-U.S. talks aimed to mitigate newly imposed tariffs, further impacting European stock indices.


Devdiscourse News Desk | Updated: 06-08-2025 22:19 IST | Created: 06-08-2025 22:19 IST
European Stocks Tumble Amid New Tariff Shockwaves
This image is AI-generated and does not depict any real-life event or location. It is a fictional representation created for illustrative purposes only.

European shares ended the day flat on Wednesday, with early session gains wiped out by a new tariff threat from U.S. President Donald Trump, targeting pharmaceutical imports. The pan-European STOXX 600 index fell 0.06%, ending its brief upward trend, largely influenced by tumbling healthcare stocks.

The healthcare sector suffered a significant downturn, with its index plummeting 2.8% to reach its lowest point in over three months, following the unveiling of a tiered tariff plan by Trump. These tariffs could potentially escalate to 250% within 18 months, affecting European and Asian markets differently as exporters grapple with repercussions.

In related economic movements, Swiss President Karin Keller-Sutter held discussions with U.S. Secretary of State Marco Rubio over potential trade resolutions, as Trump's announcement of a 39% tariff on Swiss goods posed a threat to the Swiss economy. Elsewhere, the Swiss SMI index saw a 0.9% decline amid decreased valuations of pharmaceutical giants like Novartis and Roche.

(With inputs from agencies.)

Give Feedback